Report/eBook

ASH 2023: Ones to Watch

December 7, 2023

The American Society of Hematology (ASH) Annual Meeting and Exposition is the last big clinical conference of the year. As we head into 2024, which areas are set to attract investment with their latest datasets, and which are in danger of falling flat?

ASH will see the latest data reveals on CAR-T products, multiple myeloma, leukaemia and more. In this eBook, we’ve pulled together several of the most interesting players in the space to provide a snapshot of their pipelines and commercial outlook as they present their latest datasets at the conference.

We highlight Arcellx, Gilead, Regeneron, Vertex and MorphoSys ahead of their data reveals at ASH 2023.

Download Now

Click to read ASH Preview: Ones to Watch

Share

Related Blogs

Understand the context. Data-driven news and analysis for the pharma, biotech and medtech sectors.

October 2, 2024

In Case You Missed It: Three Things we Learned in our Dealmaking Trends Webinar

If there’s one thing that the experts at Evaluate love, it’s rummaging around in data to identify trends in the pharma market. One area that is always fascinating to explore ...

September 27, 2024

2024 Dealmaking: What’s the Score?

Volume is up but value is down. That’s the headline of the dealmaking scene for the first half of 2024. There’s not been a mega-merger in the vein of 2023’s ...

August 8, 2024

Meet the Team: Kelly Chamberlain

Kelly Chamberlain may not have been at the company very long, but that didn’t stop me swooping in to find out a little more about her. Kelly has joined Norstella, ...

August 6, 2024

In Case You Missed It: Three Things we Learned in our AI Forecasting Webinar

If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re ...

July 24, 2024

Unlocking the Power of AI in Pharmaceutical Forecasting

There is no shortage of discussion about the opportunities presented by artificial intelligence and AI in the pharma industry. 50% of global healthcare companies plan to implement AI strategies by ...

July 18, 2024

In Case You Missed It: Three Things we Learned in our World Preview Webinar

Evaluate’s annual World Preview report is a must-read for many in the pharma industry. Each year, we pull together some of our key pharma forecasts to build a picture of ...